Insider filing · NBIX
Gary A Lyons
Director
profile →
Gary A Lyons sold $2.3M of Neurocrine Biosciences (NBIX)
Executed Dec 3 2025, disclosed Dec 4 2025, 1 day later.
Value, as filed
$2.3M
15,000 sh × $152.61
Executed
Dec 3 2025
the trade date, as filed
Disclosed
Dec 4 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
GLGary A Lyons (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $2.3M of NBIX (15,000 sh × $152.61, as filed), executed Dec 3 2025.
The name
NBIX
Neurocrine Biosciences, Inc.
NBIX · Healthcare · 59 filings in 24 months
ticker →
Healthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→